Trial Profile
A Randomized, Double-Blind, Placebo- and Active-Controlled Study of DS-5565 for Treatment of Pain Associated with Fibromyalgia
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Mirogabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 17 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 20 Aug 2015 New trial record